Market Cap (In USD)
2820.00
Revenue (In USD)
88.66 Thousand
Net Income (In USD)
-767.22 Thousand
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0E-4-2.0E-4
- PE
- -
- EPS
- -
- Beta Value
- 1406.62
- ISIN
- US03815L1026
- CUSIP
- 03815L102
- CIK
- 1607549
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Christopher Michael Bridges
- Employee Count
- -
- Website
- https://www.appliedbiocorp.com
- Ipo Date
- 2016-02-09
- Details
- Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
More Stocks
-
HAVELLSHavells India Limited
HAVELLS
-
OAL
-
HEWA
-
MNDPMundus Group, Inc.
MNDP
-
NAZARANazara Technologies Limited
NAZARA
-
EPR-PGEPR Properties
EPR-PG
-
STM
-
SMI